Leah Lawrence

Leah Lawrence is a freelance health writer and editor based in Delaware. Her work has appeared on several websites, including GU Oncology Now, Cancer Nursing Today, and Blood Cancers Today.

Articles by Leah Lawrence

Leah LawrenceTesticular, Penile, and Rare Malignancies | February 2, 2024
Testicular cancer experts discuss current practices and challenges related to staging, treatment, and survivorship.
Read More
Leah LawrenceNon-Muscle Invasive Urothelial Carcinoma | August 25, 2023
Several urologists weigh in on BCG, its role in NMIBC treatment, shortages, and strategies to treat BCG-unresponsive disease.
Leah LawrenceLocalized Renal Cell Carcinoma | July 7, 2023
Several experts discuss the evolution of nephrectomy, how it is used today, which patients are best suited for it, and more.
Leah LawrenceProstate Cancer | October 12, 2023
Several physicians highlight the newest data on radiation for metastatic prostate cancer and its role moving forward.
Leah LawrenceRenal Cell Carcinoma | August 23, 2023
Nivolumab plus ipilimumab showed “modest clinical efficacy” in patients with nccRCC in a study of real-world data from ...
Leah LawrenceUncategorized | December 27, 2022
5-ARIs, used in the treatment of benign prostatic hyperplasia and androgenic alopecia, may be associated with depression.
Leah LawrenceRenal Cell Carcinoma | December 27, 2022
The incidence and mortality from kidney cancer increased from 1990-2019 across most of the EU 15+ countries and WHO regions.
Leah LawrenceProstate Cancer | December 20, 2022
Care cascade after receipt of a low-value PSA testing occurred commonly among veterans enrolled in both the VHA and Medicare.
Leah LawrenceProstate Cancer | December 20, 2022
The IRONMAN registry has enrolled an international cohort of patients with newly diagnosed prostate cancer.
Leah LawrenceProstate Cancer | December 20, 2022
A genetic testing model for prostate cancer patients boosted testing compliance and decreased turnaround time for results.
Leah LawrenceNon-Muscle Invasive Urothelial Carcinoma | December 13, 2022
Endoscopic balloon cryoablation is an effective therapy for transurethral resection of non-muscle invasive bladder cancer.
Leah LawrenceProstate Cancer | December 13, 2022
Researchers developed a prostate cancer model with high discrimination and good calibration for predicting incident disease.
Leah LawrenceUpper Tract Urothelial Carcinoma | December 19, 2022
A delay in definitive radical cystectomy or radical nephro-ureterectomy is associated with poor survival in UTUC patients.
Leah LawrenceProstate Cancer | December 8, 2022
Screening using an MRI-directed targeted biopsy in men with an elevated PSA level reduced the risk for overdiagnosis by half.
Leah LawrenceRenal Cell Carcinoma | December 7, 2022
The results also showed a 46% best overall response rate in the study’s intention-to-treat population.
Leah LawrenceLocalized Renal Cell Carcinoma | December 13, 2022
Cryoablation and heat-based thermal ablation represent alternative management options for frail and/or comorbid RCC patients.
Leah LawrenceProstate Cancer | November 29, 2022
Two studies emphasize the need for ethnically diverse prostate cancer genomics data and accessible genetic testing.
Leah LawrenceProstate Cancer | November 29, 2022
An analysis of enrollment incidence ratios revealed that Black & Hispanic patients were both underrepresented in U.S. trials.
Leah LawrenceProstate Cancer | December 8, 2022
There was an improvement in freedom from PSA progression among patients assigned to enzalutamide compared with placebo.
Leah LawrenceRenal Cell Carcinoma | November 30, 2022
Patients who had single-fraction SABR had better performance status and less local failures compared with multifraction SABR.